Asserter profile
OrbiMed Royalty & Credit Opportunities III, LP
unclassified0 patents now5 ever0 cases filed during tenure2 connections
Also seen as: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
PTAB exposure
2of this entity’s patents have been challenged at PTAB (2 total proceedings).
Two-hop network
Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.
flowchart LR
Norbimed_royalty_and_credit_opportunities_iii["OrbiMed Royalty & Credit Opportunities…"]
Naegis_therapeutics_and_neurelis["Aegis Therapeutics, LLC and Neurelis, I…"]
Nneurelis_and_aegis_therapeutics["Neurelis, Inc. and Aegis Therapeutics,…"]
Naegis_therapeutics_and_neurelis -->|"2021 · Security Agreement · 11793786"| Norbimed_royalty_and_credit_opportunities_iii
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 11793786"| Naegis_therapeutics_and_neurelis
Naegis_therapeutics_and_neurelis -->|"2023 · Security Agreement · 12599611"| Norbimed_royalty_and_credit_opportunities_iii
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 12599611"| Nneurelis_and_aegis_therapeutics
Naegis_therapeutics_and_neurelis -->|"2022 · Security Agreement · 12337061"| Norbimed_royalty_and_credit_opportunities_iii
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 12337061"| Naegis_therapeutics_and_neurelis
Naegis_therapeutics_and_neurelis -->|"2021 · Security Interest · 12324852"| Norbimed_royalty_and_credit_opportunities_iii
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 12324852"| Naegis_therapeutics_and_neurelis
Naegis_therapeutics_and_neurelis -->|"2021 · Security Agreement · 11241414"| Norbimed_royalty_and_credit_opportunities_iii
Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 11241414"| Naegis_therapeutics_and_neurelis
classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
class Norbimed_royalty_and_credit_opportunities_iii focal
class Naegis_therapeutics_and_neurelis operating
class Nneurelis_and_aegis_therapeutics operating
Patents previously held (5)
- US 123248522021-08-06 → 2021-12-13
- US 123370612022-06-03 → 2024-11-14
- US 125996112023-06-04 → 2024-11-14
Connected entities (2)
- Aegis Therapeutics, LLC and Neurelis, Inc.operating company5 patents
- Neurelis, Inc. and Aegis Therapeutics, LLCoperating company1 patent